Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1/2 11Phase 1 9Phase NA 2Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 5Head and Neck Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Rectal Neoplasms 3Pancreatic Neoplasms 2Tongue Neoplasms 1Skin Neoplasms 1Gastrointestinal Neoplasms 1Digestive System Neoplasms 1Colorectal Cancer Liver Metastases 1Colonic Neoplasms 1

Interventions

Standard of Care 18Gemcitabine 18Radiosurgery 14Drug Therapy 13Blood Specimen Collection 13Endoscopic Ultrasound-Guided Fine Needle Aspiration 11Exercise 10Pancreaticoduodenectomy 9Practice Guidelines as Topic 8Methods 8Magnetic Resonance Spectroscopy 8Biopsy, Fine-Needle 8Capecitabine 7Early Intervention, Educational 6Biopsy 6Surveys and Questionnaires 5Stents 5Specimen Handling 5Resistance Training 5Radiofrequency Ablation 5Psychiatric Rehabilitation 5Oxaliplatin 5Fluorouracil 5Cholangiopancreatography, Endoscopic Retrograde 5130-nm albumin-bound paclitaxel 5Secretin 4Radiotherapy 4Irinotecan 4Heavy Ion Radiotherapy 4Electroporation 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Pancreatic Neoplasms × Cetuximab × Clear all
NCT02241187 2017-09-27

Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection

Memorial Sloan Kettering Cancer Center

Phase NA Completed
2 enrolled 4 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00448838 2016-12-15

Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

University of Miami

Phase NA Completed
42 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡